Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Current Leases (2019 - 2025)

Abeona Therapeutics has reported Current Leases over the past 7 years, most recently at $864000.0 for Q4 2025.

  • Quarterly results put Current Leases at $864000.0 for Q4 2025, up 4.98% from a year ago — trailing twelve months through Dec 2025 was $864000.0 (up 4.98% YoY), and the annual figure for FY2025 was $864000.0, up 4.98%.
  • Current Leases for Q4 2025 was $864000.0 at Abeona Therapeutics, up from $102000.0 in the prior quarter.
  • Over the last five years, Current Leases for ABEO hit a ceiling of $1.8 million in Q1 2022 and a floor of $102000.0 in Q3 2025.
  • Median Current Leases over the past 5 years was $1.7 million (2021), compared with a mean of $1.4 million.
  • Biggest five-year swings in Current Leases: increased 12.21% in 2024 and later tumbled 90.35% in 2025.
  • Abeona Therapeutics' Current Leases stood at $1.8 million in 2021, then decreased by 2.48% to $1.8 million in 2022, then tumbled by 43.71% to $998000.0 in 2023, then fell by 17.54% to $823000.0 in 2024, then increased by 4.98% to $864000.0 in 2025.
  • The last three reported values for Current Leases were $864000.0 (Q4 2025), $102000.0 (Q3 2025), and $537000.0 (Q2 2025) per Business Quant data.